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mammography cancer preventive services, veterans are less likely to have had a 
mammogram in the past year controlling for a wide range of socio-demographic 
variables. There is no significant difference in women veterans and women non-vet-
erans and their utilization of pap smears in the 2011 data. ConClusions: Despite 
documented evidence in early cancer detection, take up rates for mammography 
and colonoscopy among US veterans appears lower than non veterans. Veterans may 
not be accessing the prevention services available to them in the VA and perhaps 
awareness and education can increase these rates in the future.
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ImPact Of a RHeumatOId aRtHRItIS PatHway On cOSt Of caRe
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objeCtives: To analyze cost savings for the first year of a rheumatoid arthritis 
(RA) pathway program. Cardinal Health collaborated with CareFirst BlueCross 
BlueShield to develop the first payer-sponsored RA pathway program in the 
United States. Private-practice rheumatologist participation was voluntary, but 
reimbursement enhancements were offered to mitigate cost of pathway adoption 
and compliance. A steering committee comprised of 12 participating physicians 
created the pathway, which included an obligatory use of a real-time decision 
support and data capture tool; use of disease-modifying antirheumatic drugs 
(DMARDs) as first-line treatment for at least 12 weeks prior to use of biologic 
agents; and a requirement that dose, schedule, and adjustments for biologic agents 
follow package label prescribing guidelines. Methods: 80 physicians in 37 prac-
tices participated in the program; 876 active treatment patients were accrued 
from 2/1/12-1/31/12. Claims data augmented and validated tool-data capture. A 
first month to last month trend design was used to calculate savings regarding 
the percentage of patients initially treated with DMARDs and the use of biologic 
agents by label dose and schedule. A matched control design was used to asses 
savings for site of care based on the percentage of patients who received office-
based versus hospital-based infusions among participating and nonparticipating 
community rheumatologists. Results: DMARD use increased by 7.4% over the 
first year contributing to a lower cost of care annualized at $1,069,790. Control 
of biologic “dose-creep” contributed $80,230 to further lowering cost annually. 
Average hospital facility costs per biologic infusion were near double that of 
community practice ($5000 vs $2500, respectively). Participating providers had 
80% fewer facility infusions than nonparticipating providers (11% vs 55%, respec-
tively). ConClusions: RA pathway algorithm-compliant prescribing behavior for 
DMARDs and biologics resulted in dramatic savings. Preserving community site of 
care represents a significant savings potential for RA management.
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aSSOcIatIOn Between PeRSIStent annuaL tO BIennIaL mammOgRaPHy 
ScReenIng and Stage at dIagnOSIS amOng eLdeRLy wOmen wItH 
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objeCtives: Previous studies that have evaluated the association between mam-
mography screening and stage at breast cancer (BC) diagnosis had limitations 
because they did not analyze persistence to mammography screening and did not 
distinguish screening from diagnostic mammograms. The primary objective of this 
study is to determine the association between persistence to mammography screen-
ing and stage at BC diagnosis among elderly women. Methods: A retrospective 
cohort study was conducted using Surveillance, Epidemiology, End Results (SEER)-
Medicare database. The study population consisted of elderly women age > 70 diag-
nosed with incident BC in 2007 (N = 7,945). Persistence to mammography screening 
was measured as having at least three mammograms during the 5 years prior to BC 
diagnosis. A validated algorithm with very high sensitivity and specificity was used 
to distinguish between screening and diagnostic mammograms. Chi-square tests 
and multinomial logistic regressions were performed to analyze the association 
between persistence to mammography screening and stage of BC diagnosis, after 
controlling for predisposing, enabling, need, health care use, and external environ-
ment factors. Results: Overall, 45.4% of elderly women with incident BC were 
persistent to annual or biennial screening mammograms, 26.4% were not persistent 
to annual or biennial screening mammograms and 28.2% did not have any mam-
mogram. As compared to women who did not have any mammogram, women who 
were persistent to screening mammography were significantly more likely to be 
diagnosed at earlier stages. The adjusted odds ratios were: 44.96 (95%CI= 31.3-64.4), 
10.90 (95%CI= 8.1-14.6), and 3.40 (95%CI= 2.5-4.6) for insitu, local, and regional stages, 
respectively. ConClusions: Only a minority of elderly women were persistent 
to annual or biennial screening mammograms and persistence to mammography 
screening was associated with earlier BC disease stage. Interventions designed to 
promote persistent screening mammograms among elderly women are warranted.
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ImPact Of PHaRmacISt-caLL InteRVentIOn PROgRam On new-tO-
tHeRaPy PatIentS’ medIcatIOn adHeRence
Taitel M., Jiang J.Z., Rudkin K.
Walgreen Co., Deerfield, IL, USA
objeCtives: Patients new to therapy for chronic conditions often have poor medi-
cation adherence that can lead to adverse outcomes and higher medical costs. 
Previous studies have demonstrated the benefit of pharmacist interventions to 
improve adherence. The objective of this study is to evaluate the impact of a commu-
nity pharmacist telephone call program on medication adherence in patients new 
treatment patterns of patients with NETs, and future research should investigate 
the management strategy of different symptoms in this population and its impact 
on health care resource utilization and costs.
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utILIzatIOn, cOStS and ReImBuRSement Of InPatIent tReatment Of 
acute BacteRIaL SkIn and SkIn StRuctuRe InfectIOnS amOng tHe 
medIcaRe fee-fOR-SeRVIce POPuLatIOn
LaPensee K1, Fan W1, Ciarametaro M2, Hahn B2
1The Medicines Company, Parsippany, NJ, USA, 2Evidera, Bethesda, MD, USA
objeCtives: This study of hospitalized Medicare beneficiaries with acute bacterial 
skin and skin structure infections (ABSSSI) diagnoses describes inpatient hospital 
cost and resource use by patients with primary ABSSSI infections. Methods: The 
study used Medicare Provider Analysis and Review (MedPAR) Files from 2011—2012 
containing claims for 313,646 patients in 2011 and 317,527 patients in 2012 with 
a primary ABSSSI diagnosis with Age ≥ 18 from a 100% sample of hospitalized 
Medicare beneficiaries during 2011-2012. Reimbursements were derived from 2012 
MedPAR data and costs were derived from 2010 Premier data, inflated (4.7%) to 2012 
using the October 2013 hospital producer price index (PPI) generated by the Bureau 
of Labor Statistics. Net reimbursement was analyzed by MS-DRG and LOS. The analy-
sis used regression modeling to determine factors correlated with LOS. Results: 
Median Charlson Comorbidity Index (CCI) was 3; patients tended to have more cel-
lulitis on the trunk, foot, and toe. The median LOS was three days. Sixteen percent 
of patients used the ICU/CCU. For MS-DRG 603 (Cellulitis without MCC), the most 
common MS-DRG comprising 61% of admissions, net reimbursement was positive 
when LOS ≤ 3 days, but 52% of admissions were projected to result in financial losses 
to the hospital. Age, non-minority status, Northeast census region, CCI, cellulitis on 
the leg and traumatic wound infection were correlated with longer LOS; diagnoses 
of erysipelas, diabetes without complications and drug abuse were correlated with 
shorter LOS. Median costs were $5,612. ConClusions: The median length of stay 
for Medicare patients is shorter than the indicated length of antibiotic drug treat-
ment for ABSSSI (7-10 days), implying that most patients complete treatment in 
ambulatory settings. Hospitalization cost is projected to be less than reimbursement 
for many of the most common type of ABSSSI patients.
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factORS ReLated wItH dIRect cOStS Of ReSIdentIaL mentaL HeaLtH 
SeRVIceS In SãO PauLO cIty, BRazIL: dOeS ReSIdent PROfILe affect 
cOStS?
Razzouk D, Sousa A, Cardoso A, Oliveira GG, Mari JJ
Universidade Federal de Sao Paulo, Sao Paulo, Brazil
objeCtives: Residential services costs have been associated with multiple variables 
such as resident psychiatric status and severity of symptoms, daily living skills, 
social behaviour problems, geographic region, service size, gender and age. In 2008, 
up to twenty full staffed homes were created in Sao Paulo city, in order to accommo-
date people discharged from psychiatric hospitals. Aims of this study were to esti-
mate the direct costs of staffed homes and also to explore the relationship between 
resident profile and services costs. Methods: We used a bottom-up approach for 
the estimation of direct costs according to public health service provider perspective. 
Direct costs included costs with accommodation, inpatient, outpatient and emer-
gency health services and treatment received in the previous month, in 147 subjects 
with mental disorders living in twenty full staffed homes during the year 2011. We 
evaluated resident profile (quality of life, social behaviour problems, psychiatric 
diagnosis, severity of symptoms, socio demographic characteristics) and pattern of 
health service use. Linear regression analysis was employed to verify the effect of 
resident profile on residential services costs. Results: Residential services costs 
corresponded to 89% of the total direct costs including accommodation, health care 
and medication, and of these, 62% were due to human resources costs, 8% to trans-
portation and house repairs and 7% to overhead. Residential costs were associated 
exclusively with geographic region, length of time living in psychiatric hospital and 
length of time living in residential service. Mean of residential costs per month per 
capita was U$1,750.00 (1U$= 2.00 R$-Brazilian currency). One-fourth to one-third 
of the sample presented good scores of autonomy, social behaviour and psychiatric 
status. ConClusions: Direct costs of residential services could be optimized if 
one-fourth of sample with good autonomy and appropriate social behaviour would 
be transferred to less expensive services like semi-staffed or not staffed homes.
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dIffeRenceS In tHe utILIzatIOn Of PReVentIVe SeRVIceS fOR unIted 
StateS VeteRanS and nOn-VeteRanS
Shah RT, Parker WM
Albany College of Pharmacy and Health Sciences, Albany, NY, USA
bACkgRound:: The utilization of cancer preventive care services including 
mammography, colonoscopy and pap smears in the United States remains low, 
despite their established success in reducing cancer deaths. Due to the harmful 
exposures during their service years veterans may have more negative health 
outcomes compared to nonveterans. The rising costs of cancer treatment and a 
focus on quality treatment require the public to understand how VA resources are 
being used and if they are providing high quality and effective care to our nations’ 
Veterans. objeCtives: To understand the difference in the utilization of preven-
tive services (specifically mammography, colonoscopy and pap smears) in the US 
between veterans and non veterans. Veterans have reported reasons for declining 
preventive services like previous negative results, no time to get tested, no risk 
factors, getting testing not being a priority, uninterested in knowing, and already 
infected. This paper assesses the difference in the utilization of preventive services 
with data from the Household Component (HC) of the Medical Expenditure Panel 
Survey (MEPS) from 2011. Methods: We attempted to understand the differences 
in utilization of cancer related preventative services between veterans and non-
veterans in 2011 using regression analyses. Results: For both colonoscopy and 
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factORS affectIng acceSS and adHeRence tO tHe RecOmmended LeVeL 
Of dIaBeteS caRe In tyPe II dIaBeteS aduLtS
Gala S.D., Wu W.K.
St. John’s University, Jamaica, NY, USA
objeCtives: The objective of this study was to assess realized access, determine 
the existence of equitable or inequitable access and find the factors affecting the 
adherence to the three diabetes care components. Methods: Behavioral Risk 
Factor Surveillance System (BRFSS) 2010 was used as the data source. Hierarchical 
logistic regression was used to determine equitable or inequitable access to the 
recommended levels of diabetes care. Data analysis was performed using SAS ® 
version 9.2 Results: Realized access was highest for biannual glycosylated hemo-
globin testing (80.30%) followed by annual dilated eye examination (70.39%) and 
daily self-monitoring of blood glucose (SMBG) (63.00%). Hierarchical logistic regres-
sion revealed, enabling resources drove access to recommended level of SMBG and 
HbA1c testing, while recommended level of eye exams were driven by predisposing 
characteristics. Uninsured individuals and those who did not receive diabetes edu-
cation were less least to adhere to diabetes care. ConClusions: Realized access of 
daily SMBG needs to be increased by appropriate measures. The results suggest that 
inequitable access exists for all the three diabetes care components. Thus, measures 
for increasing equitable access are recommended. Knowing the factors affecting 
adherence to diabetes care may assist intervention planners, diabetes educators and 
health care professionals in attempting to improve diabetes management.
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deteRmInIng PatIent SatISfactIOn, PeRcePtIOn Of VaLue, and 
mOnetaRy wORtH aSSOcIated wItH adHeRence PackagIng and 
PHaRmacy SeRVIceS
Pinto S.L., Bechtol R.A., Omerza K., Conner T.
The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Toledo, OH, USA
objeCtives: Pharmacists can impact the medication adherence problem by offering 
adherence packaging and specialized services. Evaluating products and services 
that alleviate this dilemma is beneficial for improving patients’ health outcomes. 
Understanding consumer perspectives are important to determine continued use 
and expansion of such products and services. Objectives include to: (1) evaluate 
patients’ satisfaction with the services, (2) assess patients’ perceptions of the value 
of adherence packaging on their medication taking behavior, and (3) determine 
a dollar amount patients’ view as a worthy investment for services. Methods: 
Patients and caregivers > 18 years of age with at least six medications, three chronic 
conditions, and six months of adherence packaging utilization at a community 
pharmacy in Toledo, Ohio were studied. Services included pharmacist-provided 
counseling, refill synchronization, follow-up phone calls, and delivery services. 
Three structured focus group sessions were conducted. Satisfaction was assessed 
using a survey with a Likert-type scale. Show of hands and discussion were used 
to determine the value/impact on medication taking behavior and outcomes. 
Monetary worth/dollar amounts were obtained through written responses to 
open-ended questions. Responses analyzed using percentages and frequency dis-
tributions. Results: Thirty patients and caregivers participated and 93% (28/30) 
were satisfied with services provided. Participants reported adherence packaging 
and services led to fewer ER visits/hospitalizations and assisted in bringing blood 
sugar and blood pressure closer to goal. Two participants felt adherence packag-
ing was priceless and could not put a monetary value on the product or services. 
Participants reported the following monetary values: up to $50 per month (adher-
ence packaging only), $75 (adherence packaging with delivery), $100 (adherence 
packaging with counseling), and $120 (adherence packaging, delivery, and coun-
seling). ConClusions: Overall, individuals were satisfied and saw value in the 
adherence packaging system and services. Evidence suggests these services posi-
tively impacted health outcomes. Payers and health plans should consider offering 
such products/services to their customers.
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mILItaRy VeteRanS’ PeRcePtIOnS Of dISagReement wItH tHeIR PROVIdeR 
RegaRdIng tHeIR medIcaLLy unexPLaIned SymPtOmS aRe aSSOcIated 
wItH LOweR SatISfactIOn and IntentIOnS tO adHeRe tO tReatment 
and POOReR HeaLtH-OutcOme exPectatIOnS
Phillips L.A.1, McAndrew L.2
1The George Washington University, Washington, DC, USA, 2The State University of New York at 
Albany, Albany, NY, USA
objeCtives: Medically unexplained symptoms (MUS) are pervasive amongst 
returning veterans from military operations abroad. Veteran perceptions of MUS 
predict adherence and improvement, but little is known about patients’ perceptions 
of disagreement with their providers about MUS and its effect on adherence and 
outcome expectations. Given the inherent uncertainty on both the patient’s and 
the provider’s part regarding MUS, it is likely that there is much room for disagree-
ment, particularly perceived disagreement on the part of the patient, and a patient 
who disagrees with the provider is less likely to adhere to the providers’ recom-
mendations for treatment and therefore less likely to see improvement in his/her 
condition. This study evaluated the degree to which veterans perceive disagreement 
with their primary care providers regarding the MUS overall and the relationship of 
these perceptions to behaviors and outcomes of interest. We hypothesized that per-
ceived disagreement would significantly predict intentions to adhere, satisfaction 
with care, and expectations for MUS-improvement. Methods: Veterans (n= 180) 
experiencing MUS reported on perceived disagreement with their provider regarding 
the MUS, intentions to adhere, expectations for MUS improvement, and satisfac-
tion. Results: 33% of veterans perceived no disagreement with their provider, 
22% perceived slight/minor disagreement, 26% perceived moderate disagreement, 
10% perceived quite a bit of disagreement, and 9% perceived complete disagree-
ment. Results were as expected with significant relationships between perceived 
disagreement and intentions to adhere (r(174)= -0.21, p< 0.01) and satisfaction with 
to therapy for any of nine therapeutics classes. Methods: This prospective rand-
omized trial used claims data from a large pharmacy chain beginning in February 
2013. Patients were randomly assigned to an intervention group that received phar-
macist phone calls to discuss their newly prescribed medication within three days 
after dispensing (n= 219,611) or a control group that received no calls (n= 225,497). 
We tracked patients’ claims data for 180 days to evaluate their medication adher-
ence. Baseline demographic characteristics and therapeutic class distribution were 
compared between groups. Medication adherence was measured by Patient Days on 
Therapy (PDOT) within 180 days for every targeted therapeutic class (anti-anginal 
agents, betablockers, diuretics, anti-asthmatic and bronchodilator agents, genitou-
rinary agents, anti-depressants, anti-Parkinson, anti-coagulants, and hematologi-
cal agents) and overall. Significance was determined using ‘2 and t tests between 
intervention and control groups. Results: Both intervention and control groups 
had similar baseline demographic and therapeutic class distributions (P> 0.05). 
Comparison by therapeutic class found large variations of adherence with hema-
tological agents having the greatest adherence (PDOT= 105.57) while anti-angina 
agents had the lowest (PDOT= 47.06). The intervention group had greater adherence 
than the control group in every therapeutic class with the PDOT differences rang-
ing from 0.48 days for anti-angina agents to 2.63 days for anti-Parkinson agents 
(P≤ 0.05). Overall, the intervention group was more adherent than the control group 
(PDOT 86.27 vs. 84.79, P≤ 0.01). ConClusions: A community pharmacist telephone 
call program improved medication adherence across multiple therapeutic classes.
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SyStematIc LIteRatuRe ReVIew Of cOmPLIance and PeRSIStence 
PROgRamS In InfLammatIOn and ImmunOLOgy
Burudpakdee C.1, Kaura S.2, Gala S.1, Nanavaty M.1, Khan Z.M.2
1MKTXS, Raritan, NJ, USA, 2Celgene Corporation, Summit, NJ, USA
objeCtives: Patient compliance and persistence to pharmacotherapies is impor-
tant, especially in chronic conditions in inflammation and immunology (I&I) 
therapeutic area, to improve patient outcomes. Programs/interventions that aim 
at improving medication compliance and persistence play an important role in opti-
mizing care. Since there is a lack of relevant systematic reviews in I&I, the objective 
of this study is to provide a comprehensive understanding of the effectiveness of 
compliance and persistence programs in the I&I therapeutic area. Methods: A sys-
tematic literature search was conducted and studies were identified from PubMed, 
conference proceedings and grey literature. Selection criteria included studies pub-
lished in English, German, Spanish, Italian and French languages between January 
2008 and September 2013, that evaluated the impact of programs on medication 
compliance and/or persistence in I&I. Abstracts were screened by two researchers 
for inclusion, and discrepancy was resolved by a third researcher. Selected publica-
tions underwent full review and abstraction. Results: A total of 3,637 abstracts 
were screened, of which 29 evaluated the effectiveness of compliance and persis-
tence programs. Studies reviewed covered different countries: the US (n = 19); Italy 
and the UK (n = 2 each); Australia, Denmark, Malaysia, and Poland (n = 1 each); 
multicenter (n = 1) and unreported/no country mentioned (n = 1). The majority of 
patient programs were conducted in the osteoporosis disease area (n = 9), followed 
by inflammatory bowel disease (n = 4), and multiple sclerosis and ulcerative colitis 
(n = 3 each). The most effective interventions were one-on-one tailored counseling 
and web-based education/communications that improved medication compliance 
by 44% and 31%, respectively. Additionally, group-based motivational and problem-
solving support resulted in improvement of 12% at 24 months. ConClusions: A 
well-developed compliance program can have a significant impact on improving 
patient compliance as well as persistence to therapies. This, in turn may improve 
patient outcomes.
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tHe ReacH Of adequate PHaRmacOLOgIcaL adHeRence and tHe tIme 
neceSSaRy tO ImPROVe It afteR PeRfORmIng a PHaRmacOtHeRaPeutIc 
fOLLOw uP tO a cOHORt Of PatIentS wItH HIV. feBRuaRy 2012–june 2013
Estrada J.I.1, Serna J.A.2, Restrepo A.M.1, Cardona M.3
1CES University, Medellin, Colombia, 2UPB University, Medellin, Colombia, 3Antioquia University, 
Medellin, Colombia
objeCtives: Determine the proportion of patients who improve adherence sub-
sequent evaluated pharmacotherapeutic follow-up (PF), also, Identify the factors 
that explain the improvement of bond and the time necessary to achieve that 
result. Methods: A dynamic cohort study was performed on patients classified 
as non-adherent (205 patients). Two questionnaires were used (The use of ques-
tionnaires was authorized by the authors), the Simplified Medication Adherence 
Questionnaire developed by Hernando Knobel et al, and the Simplified Medication 
Adherence Scale developed by Ventura-Cerdá et al. The questionnaires were admin-
istered by a pharmacist during consultations of PF in which education was provided 
about the importance of adherence (the number of PF was defined at pharmacist’s 
discretion). The patient left the study when they were cataloged as adherent by both 
questionnaires. For the qualitative variables, absolute and relative frequencies were 
used, and for quantitative variables summary measures were used. For bivariate 
analysis, Log-rank test, T-Student and U-Mann Whitney were used. We worked with 
a confidence interval of 95% and alpha < 0.05. To adjust the association measures 
the Cox Proportional Hazards Model was applied. SPSS® version 21 for Windows 
(SPSS Inc. Chicago, Illinois, USA), covered by CES university was used. Results: The 
61.5% of patients improved adherence, were required 206 days or less to achieve this 
result (interquartile range: 88-460). The number of PF queries performed (p: 0,012), 
the city (p: 0,003) and area of residence (p: < 0,000), showed statistical association 
with improved adherence, of which only the city (HR for Bogota 0.39, IC 0.17-0.87; 
Cali 1.34, IC 0.75-2.4, compared with Medellin) and the number of PF (HR 0.87 IC 
0.79-0.95) maintained their relation for the multivariate analysis. ConClusions: 
The city of residence and the number of PF consultations conducted were associated 
with improved adherence. The education provided by the PF improves adherence 
in patients diagnosed with HIV, classified as non-adherent.
